SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Engel Samuel S.) "

Search: WFRF:(Engel Samuel S.)

  • Result 1-10 of 10
Sort/group result
   
EnumerationReferenceCoverFind
1.
  •  
2.
  • Aartsen, M. G., et al. (author)
  • Multiwavelength follow-up of a rare IceCube neutrino multiplet
  • 2017
  • In: Astronomy and Astrophysics. - : EDP SCIENCES S A. - 0004-6361 .- 1432-0746. ; 607
  • Journal article (peer-reviewed)abstract
    • On February 17, 2016, the IceCube real-time neutrino search identified, for the first time, three muon neutrino candidates arriving within 100 s of one another, consistent with coming from the same point in the sky. Such a triplet is expected once every 13.7 years as a random coincidence of background events. However, considering the lifetime of the follow-up program the probability of detecting at least one triplet from atmospheric background is 32%. Follow-up observatories were notified in order to search for an electromagnetic counterpart. Observations were obtained by Swift's X-ray telescope, by ASAS-SN, LCO and MASTER at optical wavelengths, and by VERITAS in the very-high-energy gamma-ray regime. Moreover, the Swift BAT serendipitously observed the location 100 s after the first neutrino was detected, and data from the Fermi LAT and HAWC observatory were analyzed. We present details of the neutrino triplet and the follow-up observations. No likely electromagnetic counterpart was detected, and we discuss the implications of these constraints on candidate neutrino sources such as gamma-ray bursts, core-collapse supernovae and active galactic nucleus flares. This study illustrates the potential of and challenges for future follow-up campaigns.
  •  
3.
  • 2019
  • Journal article (peer-reviewed)
  •  
4.
  • Akbari, Camilla, et al. (author)
  • Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD
  • 2024
  • In: JHEP Reports. - : Elsevier. - 2589-5559. ; 6:2
  • Journal article (peer-reviewed)abstract
    • Background & AimsLong-term studies of the prognosis of NAFLD are scarce. Here, we investigated the risk of major adverse liver outcomes (MALO) in a large cohort of patients with NAFLD.MethodsWe conducted a cohort study with data from Swedish university hospitals. Patients (n = 1,260) with NAFLD without cirrhosis were diagnosed through biopsy or radiology, and had fibrosis estimated through vibration-controlled transient elastography, biopsy, or FIB-4 score between 1974 and 2020 and followed up through 2020. Each patient was matched on age, sex, and municipality with up to 10 reference individuals from the general population (n = 12,529). MALO were ascertained from Swedish national registers. The rate of events was estimated by Cox regression.ResultsMALO occurred in 111 (8.8%, incidence rate = 5.9/1,000 person-years) patients with NAFLD and 197 (1.6%, incidence rate = 1.0/1,000 person-years) reference individuals during a median follow up of 13 years. The rate of MALO was higher in patients with NAFLD (hazard ratio = 6.6; 95% CI = 5.2–8.5). The risk of MALO was highly associated with the stage of fibrosis at diagnosis. In the biopsy subcohort (72% of total sample), there was no difference in risk between patients with and without non-alcoholic steatohepatitis. The 20-year cumulative incidences of MALO were 2% for the reference population, 3% for patients with F0, and 35% for F3. Prognostic information from biopsy was comparable to FIB-4 (C-indices around 0.73 vs. 0.72 at 10 years).ConclusionsThis study provides updated information on the natural history of NAFLD, showing a high rate of progression to cirrhosis in F3 and a similar prognostic capacity of non-invasive tests to liver biopsy.Impact and implicationsSeveral implications for clinical care and future research may be noted based on these results. First, the risk estimates for cirrhosis development are important when communicating risk to patients and deciding on clinical monitoring and treatment. Estimates can also be used in updated health-economic evaluations, and for regulatory agencies. Second, our results again highlight the low predictive information obtained from ascertaining NASHstatus by histology and call for more objective means by which to define NASH. Such methods may include artificial intelligence-supported digital pathology. We highlight that NASH is most likely the causal factor for fibrosis progression in NAFLD, but the subjective definition makes the prognostic value of a histological NASH diagnosis of limited value. Third, the finding that prognostic information from biopsy and the very simple Fibrosis-4 score were comparable is important as it may lead to fewer biopsies and further move the field towards non-invasive means by which to define fibrosis and, importantly, use non-invasive tests as outcomes in clinical trials. However, all modalities had modest discriminatory capacity and new risk stratification systems are needed in NAFLD. Repeated measures of non-invasive scores may be a potential solution.
  •  
5.
  • Alfredsson, Joakim, et al. (author)
  • Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS
  • 2018
  • In: Diabetes, obesity and metabolism. - : WILEY. - 1462-8902 .- 1463-1326. ; 20:10, s. 2379-2388
  • Journal article (peer-reviewed)abstract
    • Aim: To examine sex differences in baseline characteristics and outcomes in patients with type 2 diabetes and atherosclerotic vascular disease. Materials and methods: Cox models were used to analyse the association between sex and outcomes in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS), a randomized, placebo-controlled trial assessing the impact of sitagliptin on cardiovascular (CV) outcomes in patients with type 2 diabetes and atherosclerotic vascular disease. Results: A total of 4297 women and 10 374 men were followed for a median of 3.0 years. Women were slightly older and more often had cerebrovascular disease and peripheral arterial disease but less often coronary heart disease than men. At baseline, women were less likely to use aspirin or statins. The primary composite outcome of CV death, myocardial infarction, stroke, or hospitalization for unstable angina occurred in 418 women (9.7%) and 1272 men (12.3%; 3.48 vs 4.38 events/100 participant-years, crude hazard ratio [HR] 0.79, 95% confidence interval [CI] 0.71-0.89, adjusted HR 0.64, 95% CI 0.55-0.74; P amp;lt; .0001). Women also had a significantly lower risk of secondary CV outcomes and all-cause death. Conclusions: In this large prospective study of people with type 2 diabetes and CV disease, women had different CV disease burden, worse CV risk factor profiles, and less use of indicated medications than men. Despite this, women had significantly lower risk of CV events, suggesting that the cardioprotective effects of female sex extend to populations with type 2 diabetes.
  •  
6.
  • Dimov, Stefan S., et al. (author)
  • 4M Network of Excellence, Progress Report 2006-2008
  • 2008
  • In: 4M 2008. - Dunbeath : Whittles Publishing. - 9781904445760 ; , s. xv-xxxi
  • Conference paper (peer-reviewed)abstract
    • This report follows on from last year's "Progress Report 2004-2006" and gives an update on the continuing activities, such as the 4M Network cross-divisional projects and annual conference, as well as a description of the new activities in its third and forth year, such as the first 4M Summer School and Book Series. Finally, as the end of the funded lifetime of the network approaches the steps being taken to set up a 4M Association, which aims to create the organizational infrastructure to support the 4M Knowledge Community established in the last five years, are described.
  •  
7.
  • Dimov, Stefan S., et al. (author)
  • 4M Network of Excellence, Progress report 2009
  • 2009
  • In: 4M/ICOMM 2009. ; , s. s.1-9
  • Conference paper (peer-reviewed)abstract
    • This paper gives a brief overview of the activities of the 4M Network of Excellence during the last nine months of its funded period. The 4M Divisions summarise their activity and outline their plans to continue to working together in future. Finally a summary of achievements during the whole lifetime of the Network is given
  •  
8.
  •  
9.
  • Fisher, Robert S., et al. (author)
  • ILAE official report : a practical clinical definition of epilepsy
  • 2014
  • In: Epilepsia. - : Wiley-Blackwell. - 0013-9580 .- 1528-1167. ; 55:4, s. 475-482
  • Journal article (peer-reviewed)abstract
    • Epilepsy was defined conceptually in 2005 as a disorder of the brain characterized by an enduring predisposition to generate epileptic seizures. This definition is usually practically applied as having two unprovoked seizures >24h apart. The International League Against Epilepsy (ILAE) accepted recommendations of a task force altering the practical definition for special circumstances that do not meet the two unprovoked seizures criteria. The task force proposed that epilepsy be considered to be a disease of the brain defined by any of the following conditions: (1) At least two unprovoked (or reflex) seizures occurring >24h apart; (2) one unprovoked (or reflex) seizure and a probability of further seizures similar to the general recurrence risk (at least 60%) after two unprovoked seizures, occurring over the next 10years; (3) diagnosis of an epilepsy syndrome. Epilepsy is considered to be resolved for individuals who either had an age-dependent epilepsy syndrome but are now past the applicable age or who have remained seizure-free for the last 10years and off antiseizure medicines for at least the last 5years. "Resolved" is not necessarily identical to the conventional view of "remission or "cure." Different practical definitions may be formed and used for various specific purposes. This revised definition of epilepsy brings the term in concordance with common use. A PowerPoint slide summarizing this article is available for download in the Supporting Information section.
  •  
10.
  • Kehoe, Laura, et al. (author)
  • Make EU trade with Brazil sustainable
  • 2019
  • In: Science. - : American Association for the Advancement of Science (AAAS). - 0036-8075 .- 1095-9203. ; 364:6438, s. 341-
  • Journal article (other academic/artistic)
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 10
Type of publication
journal article (8)
conference paper (2)
Type of content
peer-reviewed (9)
other academic/artistic (1)
Author/Editor
Hansen, E. (2)
Bohm, Christian (2)
Kolanoski, H. (2)
Relich, M. (2)
Koepke, L. (2)
Christov, A. (2)
show more...
Boeser, S. (2)
Bai, X. (2)
Terliuk, A. (2)
Kowalski, M. (2)
Song, M. (2)
Zepeda, A. (2)
Nellen, L. (2)
Van Eijndhoven, N. (2)
Ahrens, M. (2)
Altmann, D. (2)
Archinger, M. (2)
Auffenberg, J. (2)
Baum, V. (2)
Bay, R. (2)
Tjus, J. Becker (2)
Hultqvist, Klas (2)
Berley, D. (2)
Bernardini, E. (2)
Bernhard, A. (2)
Bindig, D. (2)
Blaufuss, E. (2)
Boerner, M. (2)
Bos, F. (2)
Bose, D. (2)
Botner, Olga (2)
Braun, J. (2)
Brayeur, L. (2)
Casier, M. (2)
Cheung, E. (2)
Clark, K. (2)
Classen, L. (2)
Coenders, S. (2)
De Clercq, C. (2)
de Wasseige, G. (2)
de With, M. (2)
DeYoung, T. (2)
Diaz-Velez, J. C. (2)
Dumm, Jonathan P. (2)
Dunkman, M. (2)
Eberhardt, B. (2)
Ehrhardt, T. (2)
Eichmann, B. (2)
Euler, Sebastian (2)
Evenson, P. A. (2)
show less...
University
Uppsala University (4)
Karolinska Institutet (4)
Royal Institute of Technology (3)
Stockholm University (3)
Umeå University (2)
Linköping University (2)
show more...
Lund University (2)
Chalmers University of Technology (2)
University of Gothenburg (1)
Halmstad University (1)
Mid Sweden University (1)
RISE (1)
Swedish University of Agricultural Sciences (1)
show less...
Language
English (10)
Research subject (UKÄ/SCB)
Medical and Health Sciences (5)
Natural sciences (4)
Engineering and Technology (3)
Social Sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view